The Pharmaceutical Research Shared Resource provides a broad spectrum of pharmacological and pharmaceutical services essential to conduct of preclinical and clinical research in cancer biology, drug discovery, drug evaluation, and related areas by members of the Duke Cancer Institute (DCI). It is composed of two services: the Investigational Chemotherapy Service (ICS) and the Pharmacokinetics/ Pharmacodynamics (PK/PD) service. The ICS prepares investigational drug products, maintains drug accountability records and investigational drug inventories according to FDA and CTEP guidelines, provides design consultation, professional staff education, and implementation services for clinical research studies. Managed by and integral with the Department of Pharmacy, the ICS is staffed by a clinical pharmacist, a clinical research coordinator and clinical research specialist. ICS, which has provided services to the DCI for over 20 years, is located in the new Duke Cancer Center building adjacent to the Department of Pharmacy Cancer Center Infusion Pharmacy. PK/PD services are provided by the PK/PD Core which is located in a custom-designed analytical laboratory area contiguous with the new Duke Cancer Center building. It is managed by DCI and is equipped with state-of-the-art analytical and computational equipment. PK/PD services are based on the following primary technologies: liquid chromatography - tandem-mass spectroscopy (LC- MS/MS), HPLC-fluorescence, HPLC-UV/vis, and fluorescence/UV/vis plate readers for ELISA assays. These technologies cover 99% of any need on campus for small molecule (drugs, drug-metabolites, metabolome, biomarkers) analysis in cell culture, bodily fluids, or tissues. The Shared Resource provides cost-effective access to DCI members for key early activities related to drug development: investigational drug preparation/dispensing and PK/PD testing. The ICS is supporting more than 200 active clinical studies currently, and the PK/PD service has served 35 investigators' laboratories since 2009, including 24 DCI members' labs (representing seven of the nine CCSG-recognized Research Programs); 15 (63%) of the DCI users have peer-reviewed funding. Since 2009, Duke investigators have published 75 papers utilizing data from studies managed by the ICS and 63 papers (36 from clinical research) utilizing PK/PD data obtained through the Shared Resource.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Galaz-Montoya, Monica; Wright, Sara J; Rodriguez, Gustavo J et al. (2017) ?2-Adrenergic receptor activation mobilizes intracellular calcium via a non-canonical cAMP-independent signaling pathway. J Biol Chem 292:9967-9974
Lanier, Megan L; Park, Hyeri; Mukherjee, Paramita et al. (2017) Formal Synthesis of (+)-Laurencin by Gold(I)-Catalyzed Intramolecular Dehydrative Alkoxylation. Chemistry 23:7180-7184
Shi, Qiong; Liu, Hongliang; Han, Peng et al. (2017) Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. J Invest Dermatol 137:1749-1756
Woyach, Jennifer A; Ruppert, Amy S; Guinn, Daphne et al. (2017) BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia. J Clin Oncol 35:1437-1443
Wang, Yanru; Freedman, Jennifer A; Liu, Hongliang et al. (2017) Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Int J Cancer 141:731-743
Fayanju, Oluwadamilola M; Hall, Carolyn S; Bauldry, Jessica Bowman et al. (2017) Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer. Am J Surg 214:666-671
Leu, David; Spasojevic, Ivan; Nguyen, Huy et al. (2017) CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP5. Redox Biol 12:864-871
Sauer, Scott J; Tarpley, Michael; Shah, Imran et al. (2017) Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells. Carcinogenesis 38:252-260
Pan, Yongchu; Liu, Hongliang; Wang, Yanru et al. (2017) Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep 7:44634
Yin, Jieyun; Liu, Hongliang; Liu, Zhensheng et al. (2017) Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol Carcinog 56:1663-1672

Showing the most recent 10 out of 480 publications